Teleflex to Launch Family of Implantable Infusion Ports
January 21 2014 - 7:00AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care and surgery, has announced FDA
510(k) clearance of a full range of Polysite® Implantable Ports for
exclusive distribution in the U.S. under its ARROW® brand. These
ports have a low profile, hybrid design that combines a lightweight
plastic body and a strong titanium reservoir, and will be available
in both pressure injectable and non-pressure injectable
options.
“The ARROW® Polysite® Low Profile Hybrid Ports will further
broaden a product line that demonstrates our commitment to enhance
patient outcomes, improve safety and drive health economics in the
area of interventional access,” said Linda Beneze, President and
General Manager, Specialty Division. “We are proud to add ARROW®
Polysite® Ports to our portfolio.”
The ARROW® Polysite® Low Profile Hybrid Ports have a lightweight
body with an atraumatic profile designed to provide patient
comfort, while the strong titanium reservoir is compatible with a
range of cytotoxic drugs commonly used in chemotherapy and prevents
needle “pitting” experienced with plastic reservoirs. The ports
will be available in 6 Fr. Micro, 7 Fr. Mini, and 8 Fr. Standard
sizes with attachable polyurethane catheter. All sizes are pressure
injectable up to 5 mL/sec at 300psi and are MR conditional. Each
ARROW® Polysite® Port Kit contains a Polyperf SafeTM Safety Huber
Needle. This patented positive pressure Huber needle has a removal
system designed to reduce the risk of blood reflux and minimize
catheter occlusion by maintaining positive flush pressure during
one-handed needle removal.
About Perouse Medical
For more information, visit www.perousemedical.com.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical
devices for a range of procedures in critical care and surgery. Our
mission is to provide solutions that enable healthcare providers to
improve outcomes and enhance patient and provider safety.
Headquartered in Limerick, PA, Teleflex employs approximately
11,400 people worldwide and serves healthcare providers in more
than 140 countries. Additional information about Teleflex can be
obtained from the company's website at teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Perouse Medical, Polysite and Polyperf Safe are trademarks or
registered trademarks of Perouse Medical.
Teleflex and Arrow are trademarks or registered trademarks of
Teleflex Incorporated or its affiliates.
© 2014 Teleflex Incorporated. All rights reserved. 2014-2699
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024